For the press


  1. eLife names Damian Pattinson as new Executive Director

    Pattinson will lead eLife’s efforts to improve the communication of new research findings across the life and biomedical sciences.
  2. How fruit flies flock together in orderly clusters

    Using multiple senses, fruit flies form orderly clusters driven by fly-fly interactions.
  3. Two cancer-causing genes work together to promote metastasis

    Two genes that promote cancer development, MYC and TWIST1, work together to recruit immune cells to tumours, creating an environment that enables cancer cells to spread.
  4. Cannabinoids improve symptoms in mice with endometriosis

    Early studies in mice suggest that cannabinoids can relieve pain caused by endometriosis and pave the way for further clinical research.
  5. Chronic inflammation may turn skin-protecting antibody into a tumour promoter

    An antibody that usually helps defend the skin against harmful substances or infections may promote tumour growth during chronic tissue inflammation.
  6. eLife announces Timothy Behrens as new Deputy Editor

    Behrens, formerly a Senior Editor for eLife, is promoted to become a Deputy Editor.
  7. New molecule could help treat neurodegenerative diseases

    A potent new ‘chemical chaperone’ prevents the build-up of misfolded proteins and could pave the way for treatments for neurodegenerative diseases.
  8. Media Coverage: December roundup of eLife papers in the news

    High-profile news coverage that eLife papers generated in December 2019, including BBC News, The Guardian and The New York Times.
  9. New lung cancer drug resistance pathways found

    By identifying new ways that lung cancer cells evade current treatments, researchers have found potential new targets for anticancer drugs.
  10. Muscle weakness after sepsis linked to mitochondrial dysfunction

    New findings may explain why humans experience muscle weakness after sepsis recovery, and suggest the need for novel treatments to improve muscle health.

Enquiries about published papers, material in press and eLife may be directed to, or +44 1223 855373.

If you’re writing about an eLife study, please cite eLife as the source of the article and include a link to either the article or, preferably using our DOI: – with the article’s five-digit extension (e.g. Thank you!

All content, unless otherwise stated, is available under a Creative Commons Attribution License (CC-BY). All are free to use and reuse the content provided the original source and authors are credited.

The eLife media policy encourages authors to present and discuss their works ahead of publication and indicates that eLife does not release content under embargo, except in exceptional circumstances.

Please don’t hesitate to contact us if you have any questions.